Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs02388911
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
TLP | 3-HYDROXY-2-[(3-HYDROXY-2-METHYL- 5-PHOSPHONOOXYMETHYL-PYRIDIN-4- YLMETHYL)-AMINO]-BUTYRIC ACID | A,B,C,D | 1LW4 | 0.71 | |
N5F | (2S)-2-[({3-hydroxy-2-methyl-5- [(phosphonooxy)methyl]pyridin-4- yl}methyl)amino]hexanedioic acid | A,B | 3CBF | 0.7 | |
368 | (1R)-2-{[AMINO(IMINO)METHYL]AMINO}- 1-{4-[(4R)-4-(HYDROXYMETHYL)-1,3,2- DIOXABOROLAN-2-YL]PHENYL}ETHYL NICOTINATE | A | 1ZLR | 0.7 | |
PPE | 4-[(1,3-DICARBOXY-PROPYLAMINO)- METHYL]-3-HYDROXY-2-METHYL-5-PHOSPHONOOXYMETHYL- PYRIDINIUM | A,B | 1WKH | 0.7 | |
PPE | 4-[(1,3-DICARBOXY-PROPYLAMINO)- METHYL]-3-HYDROXY-2-METHYL-5-PHOSPHONOOXYMETHYL- PYRIDINIUM | A,B,C,D,E,F | 2EJ2 | 0.7 | |
PPE | 4-[(1,3-DICARBOXY-PROPYLAMINO)- METHYL]-3-HYDROXY-2-METHYL-5-PHOSPHONOOXYMETHYL- PYRIDINIUM | A | 1AKC | 0.7 | |
PPE | 4-[(1,3-DICARBOXY-PROPYLAMINO)- METHYL]-3-HYDROXY-2-METHYL-5-PHOSPHONOOXYMETHYL- PYRIDINIUM | A | 1GEY | 0.7 | |
BEJ | N,N-[2,5-O-[DI-4-PYRIDIN-3-YL-BENZYL]- GLUCARYL]-DI-[VALYL-AMIDO-METHANE] | B | 1EC2 | 0.74 | |
FEG | 5'-O-[(S)-{[2-(carboxymethyl)-6- hydroxy-3,5-dimethylpyridin-4-yl]oxy}(hydroxy)phosphoryl]guanosine | A | 3DAG | 0.71 | |
FEG | 5'-O-[(S)-{[2-(carboxymethyl)-6- hydroxy-3,5-dimethylpyridin-4-yl]oxy}(hydroxy)phosphoryl]guanosine | A | 3DAF | 0.71 | |
TQP | A,B | 3FRK | 0.76 | ||
VRS | VIRGINIAMYCIN S1 | 0,1,2,3,9,A, B,C,H,J,K,L, M,N,O,Q,R,S, T,U,Y,Z | 1YIT | 0.77 | |
587 | C32-O-(1-METHYL-INDOL-5-YL) 18- HYDROXY-ASCOMYCIN | A,C | 1QPL | 0.71 | |
PLT | [3-HYDROXY-2-METHYL-5-PHOSPHONOOXYMETHYL- PYRIDIN-4-YLMETHYL]-L-TRYPTOPHANE | B | 2TYS | 0.72 | |
POI | N~2~-ACETYL-N~5~-({3-HYDROXY-2- METHYL-5-[(PHOSPHONOOXY)METHYL]PYRIDIN- 4-YL}METHYL)-L-ORNITHINE | A,B | 1WKG | 0.71 | |
773 | CETHROMYCIN | 0 | 1NWX | 0.7 | |
PLV | N-({3-HYDROXY-2-METHYL-5-[(PHOSPHONOOXY)METHYL]PYRIDIN- 4-YL}METHYL)-O-METHYL-L-SERINE | A,B,C,D | 1PWH | 0.7 | |
QLP | N~2~-({3-HYDROXY-2-METHYL-5-[(PHOSPHONOOXY)METHYL]PYRIDIN- 4-YL}METHYL)-L-GLUTAMINE | A,B | 2R5E | 0.7 | |
PL4 | (2S,6S)-2-amino-6-[({3-hydroxy- 2-methyl-5-[(phosphonooxy)methyl]pyridin- 4-yl}methyl)amino]heptanedioic acid | A,B | 3EI6 | 0.71 | |
T4K | A,B | 2PO3 | 0.77 | ||
858 | C32-O-(1-ETHYL-INDOL-5-YL)ASCOMYCIN | A,D | 1QPF | 0.71 | |
MS3 | N,N-[2,5-O-DIBENZYL-GLUCARYL]-DI- [VALINYL-AMINOMETHANYL-PYRIDINE] | A | 1EC3 | 0.75 | |
SYB | 4-[4-(DIMETHYLAMINO)-N-METHYL-L- PHENYLALANINE]-5-[(2S,5R)-5-[[[(3S)- 1-AZABICYCLO-[2.2.2]OCT-3-YL]THIO]METHYL]- 4-OXO-2-PIPERIDINECARBOXYLIC ACID]VIRGINIAMYCIN | A,B | 2Z2P | 0.71 | |
SYB | 4-[4-(DIMETHYLAMINO)-N-METHYL-L- PHENYLALANINE]-5-[(2S,5R)-5-[[[(3S)- 1-AZABICYCLO-[2.2.2]OCT-3-YL]THIO]METHYL]- 4-OXO-2-PIPERIDINECARBOXYLIC ACID]VIRGINIAMYCIN | 0,1,3,9,A,B, C,H,J,K,L,M, N,O,Q,R,S,T, U,Y,Z | 1YJW | 0.71 | |
SYB | 4-[4-(DIMETHYLAMINO)-N-METHYL-L- PHENYLALANINE]-5-[(2S,5R)-5-[[[(3S)- 1-AZABICYCLO-[2.2.2]OCT-3-YL]THIO]METHYL]- 4-OXO-2-PIPERIDINECARBOXYLIC ACID]VIRGINIAMYCIN | 0 | 1SM1 | 0.71 | |
CBA | N-PYRIDOXYL-2,3-DIHYDROXYASPARTIC ACID- 5-MONOPHOSPHATE | A | 1IVR | 0.7 | |
KAM | N-[7-KETO-8-AMINOPELARGONIC ACID]- [3-HYDROXY-2-METHYL-5-PHOSPHONOOXYMETHYL- PYRIDIN-4-YL-METHANE] | A | 1DJ9 | 0.71 | |
GGV | B | 3GGV | 0.71 | ||
TIT | N-((3S,4S)-5-[(4-BROMOBENZYL)OXY]- 3-HYDROXY-4-{[N-(PYRIDIN-2-YLCARBONYL)- L-VALYL]AMINO}PENTANOYL)-L-ALANYL- L-LEUCINAMIDE | A,B | 1W6H | 0.7 | |
RDF | N-ALPHA-L-RHAMNOPYRANOSYLOXY(HYDROXYPHOSPHINYL)- L-LEUCYL-L-TRYPTOPHAN | A | 1DMT | 0.7 | |
RDF | N-ALPHA-L-RHAMNOPYRANOSYLOXY(HYDROXYPHOSPHINYL)- L-LEUCYL-L-TRYPTOPHAN | A | 3DWB | 0.7 | |
RDF | N-ALPHA-L-RHAMNOPYRANOSYLOXY(HYDROXYPHOSPHINYL)- L-LEUCYL-L-TRYPTOPHAN | A | 3DBK | 0.7 |